A Smarter Cancer Treatment, Beyond Biomarkers

February 21, 2025

Cancer treatment is an ongoing battle, with tumors constantly evolving and biomarker therapies benefiting only 8% of patients. Big Pharma’s approach—dividing patients into smaller groups fails to offer a scalable solution. Oncology CoPilot changes the game, using gene expression and AI to match patients with existing FDA-approved therapies, delivering effective treatment now. No more chasing mutations—this powerful tool is designed for tumor boards and oncologists to navigate complex cases and provide truly personalized care.